Search research articles
Contact Us
Filters
Showing results (11-20 of 86) with videos related to
Page
of 9
Sort By:
Neuroscience and Biobehavioral Reviews
|
July 1, 2004
Effects of drugs that potentiate GABA on extinction of positively-reinforced operant behaviour
Julian C Leslie, David Shaw, Ciara McCabe, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 5, 2021
Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment
Gerard R Dawson, Anke Post, Trevor S Smart, et al.
European Journal of Pharmacology
|
October 29, 2005
Role of GABAA alpha5-containing receptors in ethanol reward: the effects of targeted gene deletion, and a selective inverse agonist
David N Stephens, Jana Pistovcakova, Lynn Worthing, et al.
Pharmacological Research
|
August 21, 2025
All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants
Florian Freudenberg, Christine Reif-Leonhard, Gerard R Dawson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2005
Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates
James K Rowlett, Donna M Platt, Snjezana Lelas, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 9, 2010
Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze
Elena Antonova, David Parslow, Michael Brammer, et al.
Neuropharmacology
|
September 25, 2007
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist
David J Nutt, Marie Besson, Susan J Wilson, et al.
Journal of the Experimental Analysis of Behavior
|
April 7, 2006
Effects of reinforcement schedule on facilitation of operant extinction by chlordiazepoxide
Julian C Leslie, David Shaw, Gillian Gregg, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 2009
Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes
Nancy A Ator, John R Atack, Richard J Hargreaves, et al.
Neuroreport
|
July 3, 2004
The GABA-A beta3 subunit mediates anaesthesia induced by etomidate
Gillian F O'Meara, Richard J Newman, Rosa L Fradley, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 86) with videos related to
Sort By:
Page
of 9
Neuroscience and Biobehavioral Reviews
|
July 1, 2004
Effects of drugs that potentiate GABA on extinction of positively-reinforced operant behaviour
Julian C Leslie, David Shaw, Ciara McCabe, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 5, 2021
Accuracy in recognising happy facial expressions is associated with antidepressant response to a NOP receptor antagonist but not placebo treatment
Gerard R Dawson, Anke Post, Trevor S Smart, et al.
European Journal of Pharmacology
|
October 29, 2005
Role of GABAA alpha5-containing receptors in ethanol reward: the effects of targeted gene deletion, and a selective inverse agonist
David N Stephens, Jana Pistovcakova, Lynn Worthing, et al.
Pharmacological Research
|
August 21, 2025
All roads lead to glutamate: NMDA and AMPA receptors as targets for rapid-acting antidepressants
Florian Freudenberg, Christine Reif-Leonhard, Gerard R Dawson, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 13, 2005
Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates
James K Rowlett, Donna M Platt, Snjezana Lelas, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 9, 2010
Scopolamine disrupts hippocampal activity during allocentric spatial memory in humans: an fMRI study using a virtual reality analogue of the Morris Water Maze
Elena Antonova, David Parslow, Michael Brammer, et al.
Neuropharmacology
|
September 25, 2007
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonist
David J Nutt, Marie Besson, Susan J Wilson, et al.
Journal of the Experimental Analysis of Behavior
|
April 7, 2006
Effects of reinforcement schedule on facilitation of operant extinction by chlordiazepoxide
Julian C Leslie, David Shaw, Gillian Gregg, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 2009
Reducing abuse liability of GABAA/benzodiazepine ligands via selective partial agonist efficacy at alpha1 and alpha2/3 subtypes
Nancy A Ator, John R Atack, Richard J Hargreaves, et al.
Neuroreport
|
July 3, 2004
The GABA-A beta3 subunit mediates anaesthesia induced by etomidate
Gillian F O'Meara, Richard J Newman, Rosa L Fradley, et al.
Page
of 9